|
Mubarakshina O.A., Batishcheva G.A., Zhdanova O.A., Volynkina A.P., Grechushkina I.V.
Therapeutic use of amaranth oil: current trends and prospects of use
|
№4 / 2025
|
|
O.S. Elsukova, E.A. Nikitina
Efficiency of a fixed combination of insulin glargine and lixisenatide in everyday clinical practice
|
№2 / 2025
|
|
I.V. Glinkina, A.V. Oderiy, A.P. Galkina, G.Sh. Berdygylydzhova, V.V. Fadeev
Deintensification of insulin therapy in elderly patients with type 2 diabetes mellitus: impact on glycemic control and risk of hypoglycemia
|
№2 / 2025
|
|
N.A. Demidov
Dynamics of the structure of non-insulin antihyperglycemic drug use in the treatment of type 2 diabetes mellitus (data from the Moscow segment Federal Diabetes Registry)
|
№2 / 2025
|
|
Ignatenko G.A., Bagriy A.E., Mikhailichenko E.S., Prikolota A.V., Mogilevskaya K.E., Sabelnikova Ya.S., Belikov V.A.
Potentials for the use of azilsartan and spironolactone in patients with arterial hypertension and diabetes mellitus
|
№8 / 2024
|
|
Antsiferov M.B., Koteshkova O.M., Antsiferova D.M., Romashkina L.P., Golubeva Yu.V.
Efficacy and safety of the russian GLP-1 receptor agonist Quincenta (semaglutide) in patients with type 2 diabetes mellitus in real clinical practice (QUINPROMIS study. Interim data)
|
№8 / 2024
|
|
Elsukova O.S., Nikitina E.A.
Evaluation of non-glycemic effects of a fixed combination of alogliptin and pioglitazone
|
№8 / 2024
|
|
Kurnikova I.A., Chekalina M.S., Ualikhanova A.U.
Optimization of approaches to the treatment of obesity in patients with type 2 diabetes mellitus
|
№8 / 2024
|
|
Markina J.M.
Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age
|
№2 / 2024
|
|
Elsukova O.S., Nikitina E.A., Chuprova A.V., Kaysina O.A.
Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice
|
№2 / 2024
|
|
Demidova I.Yu., Boeva V.V.
Screening, diagnosis and treatment of early carbohydrate metabolism disorders
|
№2 / 2024
|
|
Antsiferov M.B., Antsiferova D.M., Koteshkova O.M., Demidov N.A.
The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow
|
№2 / 2024
|